Diabetes Drug Discovery

Diabetes Drug Discovery
Version:
21293

Year:
2022

 

In vitro panels and In vivo animal models to evaluate diabetes drug candidates

 

Diabetes Drug Discovery services provide a comprehensive clinically relevant target profile for your drug candidates with in vitro panels including Insulin Release Panel and Insulin Sensitivity Panel. Each panel is used to help understand the mechanism of action of candidate drugs and identify hits. All targets in these panels are also available to be tested individually. Our partner lab Pharmacology Discovery Services (PDS) in addition provides several in vivo diabetes models for preclinical efficacy evaluation.